To the Editor We recently read the article by Ye et al with great interest. This study contributes significantly to understanding the utility of the Fracture Risk Assessment Tool (FRAX) in predicting fracture risk among patients with cancer, an area with substantial clinical importance given the heightened vulnerability of this population. Although the study contributes significantly to our understanding, its results need cautious interpretation for several reasons.